iconplc.com is a domain
that was created on 2007-09-08,making it 17 years ago.
It has several subdomains, such as video.iconplc.com
careers.iconplc.com , among others.
Description:ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device...
Keywords:icon clinical research, icon, icon plc, clinical research orgnisation, CRO, outsourced...
Discover iconplc.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 167.884 KB |
Page Load Time: 0.189389 Seconds |
Website IP Address: 52.50.61.212 |
The Pink Ladies Organisation for Missing Children - Pink Ladies Organisation |
Clinical Research Conferences | Clinical Case Reports | Clinical Trials Conferences | Clinical Resea |
Very Icon - the best icon search engine |
Paul Calabresi K12 Career Development Award Program in Clinical Oncology | Clinical Research Trainin |
HUB Clinical Research Resources | Clinical Research Resource HUB |
Wright State University and Premier Health Clinical Trials Research Alliance | Clinical Trials Resea |
PRA Health Sciences | Clinical Trials & Clinical Research |
ProSciento Clinical R&D CRO Services for Metabolic Drug |
Clinical Research, Pharmaceutical, Medical Device Jobs | ICON Careers |
CRO for Drug Biologic & Medical Device Programs Medpace |
Full Service CRO Lab & Clinical Trials Management Frontage |
We've developed 18 of the world's top 20 best selling drugs https://www.iconplc.com/about |
Investors | ICON plc https://investor.iconplc.com/ |
ICON Webinar Channel https://webinars.iconplc.com/ |
ICON plc | Clinical Research Organisation (CRO) for Drug ... https://wwwint.iconplc.com/ |
ICON plc | Clinical Research Organisation (CRO) for Drug ... https://www.iconplc.com/ |
ICOPHONE LOGIN https://icophone.iconplc.com/ |
We've developed 18 of the world's top 20 best selling drugs http://wwwint.iconplc.com/about/ |
Sectors https://www.iconplc.com/sectors |
Investigators https://wwwint.iconplc.com/investigators/ |
ICON plc | Clinical Research Organisation (CRO) for Drug Development https://www2.iconplc.com/ |
ICON plc Reports Full Year 2022 Results | Financial Results https://www.iconplc.com/news-events/press-releases/icon-reports-fourth-quarter-and-full-year-2022-results |
Laboratory Services and Testing | Services | ICON plc https://www.iconplc.com/solutions/laboratories |
Webinars | ICON plc https://www.iconplc.com/news-events/events/webinars |
Annual Reports | ICON plc https://investor.iconplc.com/financials-filings/annual-reports |
Investors | ICON plc https://investor.iconplc.com/investors |
A iconplc.com. 300 IN A 52.50.61.212 |
MX iconplc.com. 26 IN MX 10 eu-smtp-inbound-1.mimecast.com. |
NS iconplc.com. 21600 IN NS brit.ns.cloudflare.com. |
TXT iconplc.com. 300 IN TXT HDUqRSmIspvAwxDep+eAh/caG8rv+vYcVtihZmNlZVRzVKMPWxGlzGcdRhBHaP6GLEK28ojnrf8KTjcHH9EyXg== |
SOA iconplc.com. 1800 IN SOA brit.ns.cloudflare.com. dns.cloudflare.com. 2341080681 10000 2400 604800 1800 |
Content-Type: text/html; charset=UTF-8 |
Cache-Control: max-age=60, public, s-maxage=86400 |
X-Drupal-Dynamic-Cache: MISS |
Content-Language: en |
X-Content-Type-Options: nosniff |
X-Frame-Options: SAMEORIGIN |
Expires: Sun, 19 Nov 1978 05:00:00 GMT |
X-Generator: Drupal 10 (https://www.drupal.org) |
Last-Modified: Tue, 14 May 2024 16:44:51 GMT |
ETag: "1715705091-gzip" |
X-Request-ID: v-48a40dec-1211-11ef-809e-f767d27b6fe5 |
X-AH-Environment: prod |
X-Cache-Hits: 44 |
X-Age: 149 |
X-Akamai-Transformed: 9 29219 0 pmb=mRUM,1 |
Vary: Accept-Encoding |
Date: Tue, 14 May 2024 18:56:46 GMT |
Transfer-Encoding: chunked |
Connection: keep-alive, Transfer-Encoding |
Server-Timing: cdn-cache; desc=HIT, edge; dur=58, origin; dur=0, ak_p; desc="1715713006215_1751427110_373521082_5811_4525_0_244_-";dur=1 |
Strict-Transport-Security: max-age=15768000 |
charset="utf-8"/ |
content="ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries." name="description"/ |
content="icon clinical research, icon, icon plc, clinical research orgnisation, CRO, outsourced pharmaceutical services, healthcare intelligence, ICLR, clinical trials, clinical research, cro's, cro, cro services" name="keywords"/ |
content="Drupal 10 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
Ip Country: Ireland |
City Name: Dublin |
Latitude: 53.3379 |
Longitude: -6.2591 |
Toggle navigation Solutions Solutions Our solutions span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs. Read more Cardiac Safety Solutions Clinical & Scientific Operations Consulting Early Clinical Laboratories Language Services Medical Imaging Site & Patient Solutions Strategic Solutions Symphony Health Technologies Decentralised Clinical Trial Solutions End-to-end services, operational model and technology to deliver customised solutions. Real World Intelligence® Optimising real world data to drive effective outcomes and achieve regulatory authorisation. Sectors Sectors ICON provides its full range of clinical, consulting and commercial services across several industry sectors. Read more Biotech Government and Public Health Medical Device Pharmaceuticals Biotech Developing transformative therapies requires a flexible approach. ICON and You Partners making a difference. Therapeutics Therapeutics Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology Cross-therapeutics Biosimilars Cell and Gene Therapies Medical Device Paediatrics Rare & Orphan Diseases Vaccines Women’s Health Obesity A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment. Therapeutics insights ICON’s therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more. Insights Insights Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel Diversity and inclusion in clinical trials Establishing a platform for improvement Advancements in AI for site selection Using human-enabled AI to enhance decision-making and minimise risk. Optimising Biotech funding Options for biotech to maximise their funds and improve their asset development program. News & Events News & Events ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. Read more Press releases In the News Mediakit Awards Events Webinars Social media Financial Times US Pharma and Biotech Summit 16 May 2024 Webinar: Strategic approaches for first-in-human (FIH) studies and early clinical development 29 May 2024 About ICON About ICON Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. Read more Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality ICON Cares ICON Cares is our commitment to making a positive impact on our people, environment and our community. Healthcare Intelligence Clinical Research. Evolved. Careers Investors Investigators Patients Contact 日本語 简体中文 ICON Cares Translating intent to impact. Download the full ICON Cares 2023 Report The triad of trust: Navigating real-world healthcare data integration Read the whitepaper Ensuring the validity of clinical outcomes assessment data The value of rater training Read the whitepaper Advancements in Artificial Intelligence for site selection Using human-enabled AI to enhance decision-making and minimise risk Read the whitepaper A multifaceted risk factor: Addressing obesity’s impact across the disease spectrum Considerations for clinical trial design focused on obesity treatments. Optimising biotech funding whitepaper series Navigating biotech’s challenges and embracing a promising tomorrow. 2023 biotech sector survey Navigating biotech’s challenges and embracing a promising tomorrow. EMA guideline on computerised systems and electronic data in clinical trials Key considerations on the impact of the new framework of globally applicable standards. Featured Solutions Blended solutions Bespoke, seamless solutions to meet unique sponsor challenges. Digital Health Technologies ICON acquires HumanFirst, a cloud-based technology company for life sciences supporting precision measurement in patient centred clinical research. Biotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. Cardiac Safety Solutions End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies. Early Clinical and Bioanalytical Solutions Innovative early clinical solutions that will advance your drug development strategy. Site & Patient Solutions Transforming recruitment through patient-centric trials and real-world, real-time data. Market Access Expertise in mission-critical pricing, market access, and reimbursement. Webinars Strategic approaches for first-in-human (FIH) studies and early clinical development Register today. Navigating the complexity of real-world healthcare data: choosing the right tools at the right time Watch the webinar. The future of pharmacovigilance: Exploring automation and AI in literature surveillance Watch the webinar. ICON Insights 10 May 2024 Integrating Performance Studies of In-Vitro Diagnostics into Clinical Trials: A Complex Challenge Read more 10 May 2024 SDoH data analysis for proactive outcome improvement: A multilayered approach Read more 09 May 2024 Navigating the complexities of healthcare data types Read more 01 May 2024 Cross-border initiative to empower rare disease researchers Read more 26 Apr 2024 How AI could transform literature surveillance for pharmacovigilance Read more 25 Apr 2024 Complexities of running clinical trials in retinal disorders and ways to overcome them Read more 01 Apr 2024 SDoH data for efficient, patient-centred clinical trials Read more 01 Apr 2024 Insights from PHUSE US Connect 2024 Read more 27 Mar 2024 Diabesity: Overlapping pathophysiology informs multi-indication treatment Read more What’s happening in ICON Site Branding Contact About ICON Results & Reports For Clients Therapeutics Solutions Insights Technologies Content preferences Office locations ICON for Patients Volunteers Investigators Jobs & Careers Investors Suppliers News & Events Press releases Mediakit Events Social media dashboard Socials Linkedin Facebook Instagram Youtube Legal Footer © 2024 ICON plc Disclaimer Privacy & Data Cookies How can we help? Dismiss Search Modal All Search Popular search terms: Biotech Cell and Gene Therapies Consulting Early Clinical Medical Device Oncology Rare & Orphan Diseases Real World Evidence Site & Patient Recruitment Strategic Solutions...
Domain Name: ICONPLC.COM Registry Domain ID: 1204910681_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2019-09-08T18:50:09Z Creation Date: 2007-09-08T18:48:35Z Registry Expiry Date: 2029-09-08T18:48:35Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: BRIT.NS.CLOUDFLARE.COM Name Server: CORY.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:55:42Z <<<